Pharmacotherapy: A Pathophysiologic Approach, Eighth Edition: A Pathophysiologic Approach, Eighth Edition (Google eBook)

Front Cover
McGraw Hill Professional, Apr 25, 2011 - Medical - 2700 pages
1 Review
Unique Sales Handles!!
DiPiro, Pharmacotherpy is the complete global, digital and print resource in the pharmacy market. No other competitor has near the market share (95%) of the print product and with AccessPharmacy, we provide the most comprehensive print and digital component in this space. A strategy that we intend to initiate to increase our revenue in a market we dominate is to look at saleable electronic products like a PDA and target licensing opportunties more aggressively, in the Iphone and iPod arena's.

In this new edition, one of the key goals is to increase our global reach. The addition of SI units will move us into this direction, along with a greater number of global examples and clinical questions.

New 8th Edition Sales Handles!!!

  • Full Color Text! - Online Learning Center--that features additional chapters, learning objectives, interactive questions, and more
  • Delves into psychosocial issues-that affect compliance--topics related to a patient's ability to understand and manage often-complex therapy--and lifestyle changes that may reduce the need for drug therapy or improve pharmacotherapeutic outcomes.
  • Critical Presentation boxes that summarize common disease signs and symptoms
  • Therapeutic recommendations in each disease-specific chapter
  • Evaluation of Therapeutic Outcomes Information in each disease-specific chapter containing key monitoring guidelines
  • Expanded evidence-based recommendations
  • Extended coverage of the timely issue of palliative care and pain medicine
  • Digital Vision--DiPiro remains at the cornerstone of AccessPharmacy
  • Currently DiPiro represents 35% of the site's traffic We will continue to work hand in hand with AccessPharmacy
  • Monthly updates that are being posted to AccessPharmacy will continue to be posted to the DiPiro On-Line Learning Center as well.
  • Joe DiPiro is serving as editor of the monthly updates and this will continue for the 8/e
  • Global Vision---SI Units will be included in the new edition. We should see significant increases in Canadian sales and other global markets, because of this new feature
  • We have also discussed having video clips of Professors in global regions. The focus would be on how they approach and teach pharmacotherapy. Joe and Terry both have relationships with professors from overseas and will try to work with these regions to create video clips for the OLC
  • Editorial has also reached out to India, Asia and the UK to seek feedback on specific features that could increase revenue through those respective regions.
  • Unique Components with The Text--- Free Ebook download-includes the text, learning objectives and self assessment questions
  • Value Pack-Text + Casebook PDA--includes the Handbook of Pharmacotherapy, Smith-Drug Information Handbook (Saleable product)
  • New Section Content
    Cardio, Pulm, Resp.
    *Three chapters on heart failure, instead of two. Page length will remain close to same; *PFT chapter will be moved online GI
  • One new online chapter--Celiac Disease Renal
    *Glomerulonephritis move to online chapter Neuro--*Alzheimer's move from psych to neuro; *Palliative Care will be new chapter Oncology--*New chapter online
    Nutrition--*Combine chapters 143/144; *Need new obesity author New--Medication Safety Boxes

Market / Audience
Core Market=100 Schools of Pharmacy, which graduates more than 8,000 students a year
Secondary Market=PA's and Nurse Practitioners. Though we have seen that the Chisholm book may be the preference for these markets

About the Book
The Gold Standard Tradition Continues!! The gold standard text for the therapeutics course mandatory in pharmacy schools. Now in its eighth edition, this classic text continues its long-standing tradition of offering unparalleled guidance in the development of pharmaceutical care plans. The book provides a unique process of thinking about pharmacotherapy the process which uses evidence-based approaches to the drug treatment of diseases. New to this edition, includes a Free Ebook and a package price between the Pharmacotherapy Casebook and the Core Text, at a savings for Students!

Key Selling Features

  • Key Concepts in each chapter
  • Evaluation of Therapeutic Outcomes Information in each disease-specific chapter containing key monitoring guidelines
  • Critical Presentation boxes that summarize common disease signs and symptoms
  • Clinical Controversies boxes that examine complicated issues you face when providing drug therapy
  • Therapeutic recommendations in each disease-specific chapter
  • Evaluation of Therapeutic Outcomes Information in each disease-specific chapter containing key monitoring guidelines
  • New Online Only Content!--Celiac Disease, Glomerulonephritis, Oncology, PFT, Peds, Geriatric, RCT, Clinical Pharmacokinetics

Author Profiles
Joseph DiPiro, PharmD, FCCP
Executive Dean and Professor,
South Carolina School of Pharmacy

Robert Talbert, PharmD, FCCP, BCPS
Professor
University of Texas, Health Science Center

Gary Yee, PharmD, FCCP
Professor and Associate Dean for Academic Affairs
University of Nebraska, Medical Center

Gary Matzke, PharmD, FCP, FCCP
Professor and Associate Dean for Clinical Research and Public Policy
Virginia Commonwealth University School of Clinical Research and Public Policy

Barbara Wells, PharmD, FASHP, FCCP, BCPP
Dean and Professor, Executive Director of the Research Institute of Phamaceutical Sciences
University of Mississippi School of Pharmacy

L. Michael Posey, BS Pharm
Editorial Director
American Pharmacists Association

From inside the book

What people are saying - Write a review

User Review - Flag as inappropriate

i need a copy of this book

Contents

Section 1 Foundation Issues
1
Section 2 Cardiovascular Disorders
55
Section 3 Respiratory Disorders
437
Copyright

17 other sections not shown

Common terms and phrases

About the author (2011)

Author Profiles
Joseph DiPiro, PharmD, FCCP
Executive Dean and Professor,
South Carolina School of Pharmacy

Robert Talbert, PharmD, FCCP, BCPS
Professor
University of Texas, Health Science Center

Gary Yee, PharmD, FCCP
Professor and Associate Dean for Academic Affairs
University of Nebraska, Medical Center

Gary Matzke, PharmD, FCP, FCCP
Professor and Associate Dean for Clinical Research and Public Policy
Virginia Commonwealth University School of Clinical Research and Public Policy

Barbara Wells, PharmD, FASHP, FCCP, BCPP
Dean and Professor, Executive Director of the Research Institute of Phamaceutical Sciences
University of Mississippi School of Pharmacy

L. Michael Posey, BS Pharm
Editorial Director
American Pharmacists Association

Bibliographic information